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Brief CommunicationCannabinoid type 1 receptor-containing axons
innervate NPY/AgRP neurons in the mouse
arcuate nucleusYury M. Morozov 1,2,**, Marco Koch 3,4, Pasko Rakic 1,2, Tamas L. Horvath 3,*ABSTRACT
Objectives: Phytocannabinoids, such as THC and endocannabinoids, are well known to promote feeding behavior and to control energy
metabolism through cannabinoid type 1 receptors (CB1R). However, the underlying mechanisms are not fully understood. Generally, cannabinoid-
conducted retrograde dis-inhibition of hunger-promoting neurons has been suggested to promote food intake, but so far it has not been
demonstrated due to technical limitations.
Methods: We applied immunohistochemical labeling of CB1R for light microscopy and electron microscopy combined with three-dimensional
reconstruction from serial sections in CB1R-expressing and CB1R-null mice, which served as a negative control. Hunger-promoting neurons
expressing Agouti-related protein and neuropeptide Y (AgRP/NPY) in the hypothalamic arcuate nucleus were identified in NPY-GFP and NPY-hrGFP
mice.
Results: Using three-dimensional reconstruction from serial sections we demonstrated numerous discontinuous segments of anti-CB1R labeling
in the synaptic boutons and axonal shafts in the arcuate nucleus. We observed CB1R in the symmetric, presumed GABAergic, synaptic boutons
innervating AgRP/NPY neurons. We also detected CB1R-containing axons producing symmetric and asymmetric synapses onto AgRP/NPY-
negative neurons. Furthermore, we identified CB1R in close apposition to the endocannabinoid (2-arachidonoylglycerol)-synthesizing enzyme
diacylglycerol lipase-alpha at AgRP/NPY neurons.
Conclusions: Our immunohistochemical and ultrastructural study demonstrates the morphological substrate for cannabinoid-conducted feeding
behavior via retrograde dis-inhibition of hunger-promoting AgRP/NPY neurons.
 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Regulation of food intake and energy consumption is a complex system
that includes multiple regulations of brain and peripheral organs [1e
4]. As a group of lipid messengers, endocannabinoids (eCBs) have
the capability to induce synaptic plasticity by retrograde modulation of
glutamatergic and GABAergic neurotransmission in various brain areas
as well as represent important metabolic signaling molecules in pe-
ripheral organs [1,5,6]. Indeed, cannabinoid type 1 receptors (CB1R)
are well known to mediate the effects of cannabinoids on energy
metabolism [7e10]. Novel data indicate that the anorexigenic proo-
piomelanocortin (POMC) neurons reverse their function in the presence
of cannabinoids [11,12]. However, the cellular and molecular mech-
anisms behind hypothalamic CB1R activation in order to regulate en-
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dem with neurons in the hypothalamic arcuate nucleus (ARC) that co-
express Agouti-related protein (AgRP) and neuropeptide Y (NPY; [14]).
At times of negative energy balance, AgRP/NPY neurons are directly
activated by the appetite-inducing hormone ghrelin and by increased
levels of free fatty acids that are utilized in these neurons via beta-
oxidation [15]. Upon activation, AgRP/NPY neurons release neuro-
peptides as well as GABA to control behavior, in part by inhibiting
POMC neurons in the ARC [16]. In parallel to the feeding-promoting
hormone ghrelin, distinct eCBs such as 2-arachodonoylglycerol (2-
AG) are up regulated in the hypothalamus during fasting, whereas
satiety-promoting hormones such as leptin acutely reduce hypotha-
lamic 2-AG levels [7,17,18]. This prandial state-dependent fluctuation
of the retrograde messenger 2-AG indicates that eCBs might be
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studies demonstrated moderate amounts of radioactive CB1R ligand
binding as well as CB1R mRNA in hypothalamic nuclei [13,19e21].
However, AgRP/NPY neurons do not contain CB1R mRNA and it is thus
unlikely that cannabinoids directly affect the output synapses of AgRP/
NPY neurons [19]. Nevertheless, retrograde eCB modification of pre-
synaptic CB1R on glutamatergic or GABAergic axon terminals inner-
vating AGRP/NPY neurons was suggested as a putative mechanism ofFigure 1: Light and electron microscopy of the hypothalamus from CB1R-expressing
Representative light micrographs of ARC from CB1R
þ/ (A) and CB1R
/ mice (B). Equal co
numerous immunopositive particles (arrows) in CB1R
þ/ and similar but relatively rare sta
numerous immunolabeling depositions are located in thin axon-like processes (arrows); aty
between the axonal cell membrane and mitochondria (empty arrow) results from selective l
2 [27e29]. Electron micrograph from CB1R
/ shows non-selective DAB-Ni deposition in a
protein 2 (double arrow). (E and F) 3D reconstructions from serial ultrathin sections of arbitr
mode) that contain DAB-Ni depositions (depicted black; arrows). The processes in CB1R
þ
single spots of DAB-Ni deposition in CB1R
/. Red line in E indicates positioning of the pr
semitransparent colors, respectively. (G and H) Electron microscopy quantifications of the a
expressing (CB1R
þ/þ and CB1R
þ/, pooled) and CB1R
/ mice. Notice that anti-CB1R immu
this is not encountered in CB1R
/ mice (H). This confirms presence of CB1R in the axons
measurements from 4 animals in each group SD are indicated. Abbreviations: d, dendr
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remained uncertain in the ARC [6,22e24]. This inspired our immu-
nohistochemical investigation of eCB signaling in the ARC. Here, we
used transgenic mouse models and methods of electron microscopy
combined with three-dimensional (3D) reconstruction from serial
sections to evaluate the morphological substrate of presynaptic CB1R-
dependent control of AgRP/NPY neurons in the ARC.mice and CB1R
L/L littermates immunolabeled with anti-CB1R serum. (A and B)
nditions of the tissue and micrograph preparation were applied. The micrographs show
ining in CB1R
/. (C and D) Electron microscopy analysis shows that, in the CB1R
þ/,
pical staining is also present. For example, it is unclear whether the DAB-Ni deposition
abeling of membranous CB1R or cross reactivity with mitochondrial stomatin-like protein
dendrite (empty arrowhead) and mitochondrial labeling characteristic for stomatin-like
arily chosen axon-like processes (each depicted with different colors in semitransparent
/ contain numerous immunopositive fragments, whereas axon-like processes contain
ofiles shown in the electron micrograph in C where they are highlighted with the same
nti-CB1R immunolabeling in identified cell segments and organelles in ARC of the CB1R-
nolabeling predominates in the axon-like processes in the CB1R-expressing animals (G);
while dendro-somatic and mitochondrial CB1R locations are enigmatic. Averages of the
ite; sb, synaptic bouton. (Scale bars in A and B ¼ 10 mm; in CeF ¼ 0.5 mm).
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Figure 2: CB1R in synaptic boutons innervating AgRP/NPY-positive and -negative neurons in the ARC. (AeC) In 3D reconstruction, NPY-GFP-positive dendritic shaft (yellow)
contacts with CB1R-positive axon (blue). Positions of profiles shown in electron micrographs (B and C) are indicated with red dotted lines b and c, respectively. (B) NPY-GFP-
positive dendrite identified with diffuse DAB deposition (highlighted semitransparent yellow) produces symmetric synapse (arrowhead) with CB1R-positive synaptic bouton
(semitransparent blue) that is identified with intense black DAB-Ni staining. (C) The NPY-GFP-positive dendrite is also innervated by two symmetric synapses (arrowheads) from
CB1R-negative axons. Profile of axonal shaft of the reconstructed CB1R-positive axon is indicated with empty arrow. Profiles of other CB1R-positive axons not shown in the 3D
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Mice were maintained with water and food freely available and housed
on a 12 h light/12 h dark cycle. All mice were aged between 12 and
16 weeks at the time of killing. Procedures were approved by the
Institutional Animal Care and Use Committee of Yale University.
2.2. Transgenic animals
CB1R-null (CB1R
/) mice were on a C57/BL6 background [25]. NPY-
GFP (B6.Cg-Tg(Npy-MAPT/Sapphire)1Rck/J, stock no 008321, The
Jackson Laboratories, Bar Harbor, ME USA) and NPY-hrGFP (B6.FVB-
Tg(Npy-hrGFP)1Lowl/J, stock no 006417, The Jackson Laboratories)
mice were used for identification of AgRP/NPY neurons in the ARC.
Both lines were maintained on a C57/BL6 background.
2.3. Immunohistochemistry for electron and light microscopy
For correlative light/electron microscopy, CB1R
þ/þ, CB1Rþ/, CB1R/
 and NPY-GFP mice were perfused transcardially with a fixative
containing 4% paraformaldehyde, 0.2% picric acid, and 0.2%
glutaraldehyde in 0.1 M PB. The brains were removed and immersed
overnight in the same fixative. Coronal brain sections (of 50 mm
thickness) were cut with a vibratome. About half of the brain sections
were immersed in 0.5% H2O2 for 30 min to block tissue peroxidase,
whereas the remaining specimens were used for immunohistochem-
istry omitting this step. No difference in the immunolabeling was
observed between these sections. For single immunolabeling, the
sections were incubated with polyclonal sera against CB1R raised in
guinea pig (1:1000; CB1-GP-Af530; Frontier Institute, Ishikari, Hok-
kaido, Japan), then, with biotinylated anti-guinea pig IgGs (1:300;
Jackson Immunoresearch, West Grove, PA, USA) and the Elite ABC kit
(Vector Laboratories, Burlingame, CA, USA) with Ni-intensified 3,3ʹ-
diaminobenzidine-4HCl (DAB-Ni) as a chromogen. For CB1R/GFAP and
CB1R/NPY-GFP double labeling, the sections were first immunolabeled
for CB1R as above with DAB-Ni as a chromogen that produces
intensive black staining; then, the sections were incubated with made-
in-rat anti-GFAP (1:6000; Invitrogen, Eugene, OR, USA) or made-in-
chicken anti-GFP (1:2000; Thermo Fisher Scientific, Rockford, IL,
USA) sera. Thereafter, corresponding biotinylated anti-rat or anti-
chicken IgGs (1:300; both from Jackson Immunoresearch) and the
Elite ABC kit were applied as above. 3,3ʹ-diaminobenzidine-4HCl (DAB)
producing diffuse electron-dense staining was used as a chromogen.
The sections were post-fixed with 1% OsO4, dehydrated, embedded in
durcupan (Fluka, Buchs, Switzerland) on microscope slides, and
coverslipped. Selected fragments of tissue were analyzed and pho-
tographed with an Axioplan 2 microscope (Zeiss, Jena, Germany) and
re-embedded into durcupan blocks for electron microscopic investi-
gation. The samples were cut with a Reichert ultramicrotome into 70-
nm-thick sections. The sections were then stained with lead citrate
and evaluated and photographed in a JEM 1010 electron microscope
(JEOL, Japan) equipped with a Multiscan 792 digital camera (Gatan,
Pleasanton, CA, USA).
For 3D reconstruction, 20e30 serial images were made with 15,000
magnification of electron microscope. Neuropil fragments were chosen
for the 3D reconstruction of axon-like processes in a random mannerreconstructions are also seen (arrows in C). (D and E) 3D reconstruction from serial ultr
transparent mode) that contain plural anti-CB1R DAB-Ni depositions (depicted black; small
the profiles shown in the electron micrograph in E where they are highlighted with the sam
synapse (arrowhead) with the NPY-GFP-negative cell body (semitransparent orange). The gr
GFP-negative cell body and a dendrite. Several CB1R-positive axon-like profiles (not show
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crographs were aligned using the computer program Reconstruct [26],
publicly available at http://www.bu.edu/neural/Reconstruct.html.
For fluorescent microscopy, NPY-hrGFP mice were perfused with 4%
paraformaldehyde and 0.2% picric acid in 0.1 M PB. The brains were
removed and immersed overnight in the same fixative. Coronal brain
sections (of 50 mm thickness) were cut with a vibratome. For double
immunofluorescence staining, the sections were incubated in blocking
solution (5% normal goat serum and 0.2% Triton X-100 in 0.1 M PB)
for 60 min. The primary polyclonal antibodies (guinea pig anti-CB1R IgG
(CB1-GP-Af530); Frontier Institute, Ishikari, Hokkaido, Japan) and
rabbit anti-diacylglycerol lipase-alpha (DAGL) IgG (DGLa-Rb-Af380;
Frontier Institute) were both diluted at 1:300 and concomitantly applied
overnight at room temperature. The next day, sections were washed 3
times in 0.1 M PB and were concomitantly incubated with the sec-
ondary antibodies (goat anti-guinea pig IgG (HþL) Alexa Fluor 568
conjugate, A-11075; and, goat anti-rabbit IgG (HþL) Alexa Fluor 633
conjugate; both from Thermo Fischer Scientific, Waltham, MA, USA)
both at a dilution of 1:500 for 1 h at room temperature. Finally, the
sections were coverslipped in DAKO mounting medium and confocal
laser scanning microscopy was performed using a Zeiss LSM Meta
510.
In previous studies, we extensively analyzed specificity of the anti-
CB1R labeling using mass-spectrometry, Western Blots, and immu-
nohistochemistry at light and electron microscopy levels; we demon-
strated that anti-CB1R IgG (CB1-GP-Af530; Frontier Institute) in parallel
to CB1R also recognize a conformational epitope in mitochondrial
stomatin-like protein 2 [27e29]. Specific anti-DAGL labeling (neuronal
somato-dendritic surface expression) was confirmed for immunohis-
tochemistry at levels of light and electron microscopy using wild type
and DAGL-null mice [30e32]. Specific anti-GFP and anti-GFAP la-
beling was confirmed in numerous studies [e.g., [33,34]].
2.4. Statistical analysis
Quantifications of the anti-CB1R immunolabeling in identified cell
segments and organelles in ARC of the CB1R-expressing (CB1R
þ/þ and
CB1R
þ/, pooled) and CB1R/ mice were performed at 15,000
magnification of electron microscope. Percentages of the anti-CB1R
immuno-precipitation locations in axon-like, dendro-somatic, and
mitochondrial profiles were calculated for every measurement. Then,
averages of 4 measurements from every one of 4 animals in each
group SD were calculated using Excel 2013 (Microsoft) software.
3. RESULTS
3.1. CB1R concentrates in axon-like processes in the ARC
Raised in guinea pig anti-CB1R serum provides intensive staining of
CB1R-expressing cell bodies and axons in the cerebral cortex and
hippocampus (Supplementary Figure 1) that is similar to the immu-
nolabeling obtained with other CB1R antibodies [e.g., [35e37]]. In
contrast, anti-CB1R labeling in the hypothalamus appears as sporadic
immunopositive particles that are difficult to distinguish from back-
ground staining solely based upon light microscopy or qualitative
electron microscopy (Figure 1AeD). Nevertheless, 3D reconstruction
from serial sections reveals a dramatic difference in anti-CB1R labelingathin sections demonstrates three axons (each depicted with different colors in semi-
arrows) and innervate NPY-GFP-negative cells. Red dotted lines indicate positioning of
e semitransparent colors, respectively. The yellow synaptic bouton produces symmetric
een synaptic bouton produces asymmetric synapses (empty arrowheads) with, the NPY-
n in 3D) are highlighted semitransparent red. (Scale bars ¼ 1 mm).
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Figure 3: A three-somatic synapse in ARC from CB1R
D/D mouse identified with double immunolabeling for CB1R (DAB-Ni) and GFAP (DAB) combined with electron
microscopy 3D reconstruction. (A and B) 3D reconstruction images rotated 90 relative to each other. (C and D) Representative serial micrographs used for the 3D recon-
struction. CB1R-containing synaptic bouton (depicted semitransparent yellow in 3D and serial electron micrographs) innervates an immunonegative dendritic shaft (depicted
semitransparent indigo). The synaptic contact is shown in red in 3D and indicated with red arrowheads in the electron micrographs. Anti-CB1R intensive black DAB-Ni depositions
(arrows; depicted black in 3D) are seen in both, the synaptic bouton and axonal shafts. Another CB1R-containing axon-like process (semitransparent yellow; empty arrows) is also
seen. Notice that several of the anti-CB1R DAB-Ni depositions (arrows) contact the GFAP-positive astroglial cell (identified with diffuse DAB staining; highlighted semitransparent
light blue), but they are not inside of it. (Scale bars ¼ 0.5 mm).
Brief Communicationbetween CB1R-expressing and CB1R
/ animals. We found that each
CB1R-immunopositive process contains several discontinued de-
positions of anti-CB1R DAB-Ni immuno-precipitation in the CB1R wild
type (CB1R
þ/þ) and heterozygous (CB1Rþ/) mice. In contrast, only a
single spot of staining was detected in every 3D-reconstructed process
in CB1R
/ mice, designating occasional binding of the antibodies
(Figure 1E, F).
Additional evidence of selective labeling in the CB1R-expressing ani-
mals was obtained with quantification of the sites of DAB-Ni immuno-
precipitations in electron microscopy. Analysis of occasional single
ultrathin sections shows that 82.2  4.2% of the immuno-
precipitations in the CB1R-expressing mice are located in axon-like
processes, whereas the remaining number of immuno-precipitations
is distributed between dendrites, cell bodies, and mitochondria
(Figure 1G). Predomination of a certain location of anti-CB1R labeling
was not encountered in CB1R
/ mice. In those, non-CB1R binding of
the CB1R antibodies (presumed background or labeling of other mol-
ecules) was detected in nearly equal proportions in axon-like pro-
cesses, dendro-somatic cell segments, and mitochondria (Figure 1H).
Mind that similar mitochondrial labeling is evident in the CB1R-
expressing and CB1R
/ mice, confirming previously demonstrated
binding of the anti-CB1R serum with mitochondrial stomatin-like pro-
tein 2 rather than revealing mitochondrial location of CB1R [27e29].
In three random segments of ARC neuropil from CB1R
þ/þ mice that
were subject of electron microscopy analysis and 3D reconstruction378 MOLECULAR METABOLISM 6 (2017) 374e381  2017 The Authors. Published by Elsevier(each analyzed volume w100 mm3), we identified in total 32, 26, and
13 CB1R-positive axon-like processes per a reconstructed segment
(Supplementary Figure 2). No dendrite-like processes containing CB1R
accumulation were observed in these neuropil segments. Detected
CB1R-positive axon-like processes are separated by immunonegative
tissue and do not form CB1R-enriched bundles that would be easily
identifiable with light microscopy. Thus, our quantitative electron mi-
croscopy analysis and 3D reconstruction from serial sections
demonstrate numerous CB1R-positive axon-like processes in the
hypothalamus.
3.2. CB1R-expressing axons innervate AgRP/NPY-positive and
-negative neurons
To analyze whether the hypothalamic CB1R-expressing axons could
produce synapses innervating AgRP/NPY neurons in the ARC, we
performed double immunolabeling for CB1R and GFP in the NPY-GFP
transgenic mice. Using 3D reconstruction from serial sections, we
detected CB1R-positive synapses innervating NPY-GFP-positive den-
drites (Figure 2AeC). Among five identified synapses, all were of
symmetric morphological type, indicating that inhibitory GABAergic
inputs probably predominate among CB1R-positive synapses that
innervate AgRP/NPY neurons. In contrast, NPY-GFP-negative dendritic
shafts and cell bodies show both symmetric and asymmetric synaptic
contacts with CB1R-immunopositive axons (Figure 2D, E and Figure 3).
Thus, CB1R-containing synapses innervate AgRP/NPY and otherGmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/). www.molecularmetabolism.com
neurons, supporting the hypothesis for retrograde eCB signaling in the
ACR and predomination of eCB-conducted dis-inhibition of the AgRP/
NPY hunger promoting neurons. Further morphological study (for
example, immuno-gold labeling that provides more precise location of
the antigen) of CB1R location in the hypothalamic nuclei is warranted.
3.3. CB1R and DAGL are co-localized at AgRP/NPY neurons in ARC
To further elucidate potential CB1R signaling in ARC, we performed
immunofluorescence assay for the enzyme DAGL, which is known to
be located at postsynaptic sites catalyzing biosynthesis of the eCB
retrograde messenger 2-AG [38,39]. We observed dotted DAGL
immunolabeling as in GFP-expressing AgRP/NPY neurons so in GFP-
negative cells. Multiple immunofluorescence exemplified a close
spatial relationship between CB1R and DAGL in the ARC, particularly at
NPY-GFP neurons (Figure 4). The latter finding supports a retrograde
mode of action of 2-AG at AgRP/NPY neurons, as has been demon-
strated in other brain segments [5,29].
4. DISCUSSION
Relatively low anti-CB1R immuno-reactivity in the hypothalamus
makes identification of CB1R-containing axons with light microscopy
and in single electron micrographs difficult. Here, we addressed this
problem using electron microscopy with 3D reconstruction from serial
sections. We show that (1) numerous axons in ARC contain several
discontinuous CB1R-positive segments; (2) CB1R-positive axonsFigure 4: Immunolabeling for CB1R (red) and DAGL (blue) in ARC from the NPY-hrG
hrGFP-expressing cells (green)] are indicated with arrows. CB1R-positive DAGL-negative s
MOLECULAR METABOLISM 6 (2017) 374e381  2017 The Authors. Published by Elsevier GmbH. This is an
by-nc-nd/4.0/). www.molecularmetabolism.cominnervate AgRP/NPY neurons with mostly symmetric, presumed
inhibitory, synapses; (3) unlabeled neurons receive both symmetric
and asymmetric synaptic contacts with CB1R-positive axons; (4) DAGL
e the enzyme catalyzing biosynthesis of the eCB retrograde
messenger 2-AG e is in close apposition to CB1R at AgRP/NPY neu-
rons. Taken together, the data demonstrate the morphologic substrate
for eCB/CB1R-conducted retrograde dis-inhibition of the orexigenic
neurons in ARC.
CB1R and eCBs were shown to be involved in the regulation of food
intake and energy consumption in several hypothalamic nuclei,
including the lateral and dorsomedial hypothalamus as well as ARC
and paraventricular nucleus [1,2,11,13,19,40,41]. Moreover, eCB
prandial regulation apparently includes synaptic and non-synaptic
mechanisms [10,12,42]. A hypothalamic role of CB1R-containing
synapses in eCB regulation of food intake was suggested [19,22], but it
was not experimentally demonstrated. Our findings unravel a yet un-
known synaptic mechanism of eCB control of food intake that may act
in parallel with recently demonstrated intracellular eCB control of
mitochondrial respiration [12].
Thus, our results show that eCBs and cannabis drugs may conduct
prandial mechanisms through retrograde synaptic dis-inhibition and
dis-excitation in the hypothalamus. Further investigations are war-
ranted to determine the location and neurochemical properties of
CB1R-expressing inhibitory neurons innervating AgRP/NPY neurons in
ARC; and, to determine what neurons provide the CB1R-containing
inputs to other neurons of the hypothalamus.FP transgenic mouse. CB1R/DAGL-double positive spots [some of those are at NPY-
pots are indicated with arrowheads. (Scale bar ¼ 10 mm).
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